MyAverix Finance
BE · Healthcare
Kala Pharmaceuticals Inc (27F0)
Drug Manufacturers - Specialty & Generic
Kala Pharmaceuticals Inc (27F0) is listed on BE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 27F0
Kala Pharmaceuticals Inc (27F0) — FAQ
What is 27F0's P/E ratio?
The price-to-earnings (P/E) ratio for Kala Pharmaceuticals Inc (27F0) is 18.00 (data as of 2026-03-22).
Does Kala Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Kala Pharmaceuticals Inc (27F0). Check the MyAverix Finance app for the latest dividend data.
What sector is Kala Pharmaceuticals Inc in?
Kala Pharmaceuticals Inc (27F0) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 27F0 listed on?
27F0 is listed on BE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.